The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma
Journal of Vascular Surgery · 2026
DOI: 10.1016/j.jvs.2025.08.004 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Mohit K Manchella und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: mohitmanchella@hms.harvard.edu. Hauptthemen laut MEDLINE: Endovascular Procedures, Hematoma, Aortic Diseases, Time-to-Treatment. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Intramural hematoma (IMH) carries significant risk of morbidity and mortality, and although thoracic endovascular aortic repair (TEVAR) is increasingly used as a treatment, the optimal timing for its intervention remains uncertain. This study aimed to compare outcomes between patients undergoing urgent TEVAR (within 24 hours of admission) and those undergoing elective TEVAR (beyond 24 hours from admission). METHODS: Patients who underwent TEVAR between aortic zones 2 and 5 for IMH from 2013 to 2023 were included, excluding those with rupture. Propensity scores were generated using covariates such as age, sex, race, obesity, anemia, transfer status, hypertension, diabetes, prior myocardial infarction, congestive heart failure, smoking history, chronic obstructive pulmonary disease, cerebrovascular disease, dialysis status, medication use, and previous aortic surgery, to adjust for assignment to urgent/emergent or elective TEVAR. Perioperative outcomes were assessed using inverse probability-weighted logistic regression. Association of urgent or elective TEVAR with 5-year mortality was assessed using Cox regression stratified by IMH symptom status. RESULTS: Among 345 patients, 165 (48%) underwent elective repair. The urgent group had a higher rate of transfers from outside institutions (64% vs 43%; P = .01), were less likely to use beta-blockers before presentation (69% vs 84%; P = .003), and were more frequently symptomatic at presentation (98% vs 72%; P < .001). There were no significant differences in IMH disease extent or graft landing zones between groups. Perioperative mortality (6.3% vs 0.6%; adjusted odds ratio [aOR] 19; 95% confidence interval [CI], 3.01-764; P = .02) and reintervention during index admission (8.3% vs 2.4%; aOR, 4.92; 95% CI, 1.67-19.5; P = .01) was significantly greater in the urgent group. Five-year survival was lower in the urgent group, but this difference was not statistically significant. In symptomatic patients, the urgent cohort had significantly higher perioperative mortality (7.3% vs 0.8%; aOR, 10; 95% CI, 2.11-152; P = .02), acute kidney injury (9.0% vs 2.5%; aOR, 3.28; 95% CI, 1.12-12.1; P = .04), and reintervention (8.5% vs 2.5%; aOR, 5.26; 95% CI, 1.61-25.6; P = .01) rates. Conversely, the elective group had a longer total length of stay (32% vs 21%; aOR, 0.48; 95% CI, 0.28-0.82; P = .01). Five-year survival in the symptomatic cohort was lower in the urgent group, but this difference was not statistically significant. CONCLUSIONS: Patients undergoing urgent TEVAR for IMH experience worse perioperative outcomes compared with those undergoing elective repairs, despite comparable baseline risk profiles. Although emergent repair may be necessary in certain cases, these data advocate for a patient management strategy that prioritizes stabilization before intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: mohitmanchella@hms.harvard.edu.
- Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.
- Department of Medicine, Virginia Commonwealth University, Richmond, VA.
Zitieren
APA
Manchella, M. K., Rastogi, V., Bellomo, T. R., Summers, S., Gaston, B., Kermani, S. S., Dua, A., & Eagleton, M. J. (2026). The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.08.004
Vancouver
Manchella MK, Rastogi V, Bellomo TR, Summers S, Gaston B, Kermani SS, et al. The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2025.08.004
BibTeX
@article{Manchella2026,
author = {Manchella, Mohit K and Rastogi, Vinamr and Bellomo, Tiffany R and Summers, Steven and Gaston, Brandon and Kermani, Shaghayegh S and Dua, Anahita and Eagleton, Matthew J},
title = {The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma},
journal = {Journal of Vascular Surgery},
year = {2026},
doi = {10.1016/j.jvs.2025.08.004}
}
EUVIMED